Intuitive Surgical Stock – Fundamental Analysis

Price
420.24
10/14/2026
Jun 2000
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 9/6/2026)

Balance Sheet Total Assets 20,458,700,000.00 ROE 87.12 %
Balance Sheet Total Equity 17,824,000,000.00 ROA 13.96 %
Cashflow Capital Expenditures -539,800,000.00 P/FCF 61.20
Cashflow Free Cash Flow 2,490,700,032.00 – –
Cashflow Operating Cash Flow 3,030,500,000.00 P/CF 50.30
Income Earnings per Share (diluted) 7.87 Div. Yield –
Income Net Income 2,856,000,000.00 P/E 53.40
Income Shares Outstanding 355,100,000.00 P/B 8.55
Income Total Revenue 10,064,700,000.00 P/S 15.14

Ratios calculated on: 10/14/2026

Company Description

Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories. A da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a high performance vision system. The da Vinci Surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions, or ports. The da Vinci Surgical System is designed to provide its operating surgeon with intuitive control, range of motion, fine tissue manipulation capability and three dimensional (3-D), high-definition (HD) vision while simultaneously allowing the surgeon to work through the small ports of MIS. On January 11, 2012, the Company acquired its Korean distributor.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.intuitivesurgical.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more